Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The **Staphylococcus aureus accessory gene regulator (agr) quorum sensing system** is a central regulatory mechanism that allows S. aureus to coordinate gene expression according to population density, using a self-produced autoinducing peptide (AIP) as the communication signal[1][2][5]. The system consists of a four-gene operon (agrBDCA) encoding components for AIP synthesis (AgrD, AgrB), signal detection (the sensor histidine kinase AgrC), and transcriptional response (the response regulator AgrA)[1][3][6]. Upon reaching a threshold AIP concentration, AgrC autophosphorylates and transfers the signal to AgrA, which in turn activates two divergent promoters (P2 and P3). P2 drives operon autoregulation, while P3 induces the regulatory RNA, RNAIII, controlling multiple virulence factors including toxins and surface proteins[2][4][3]. The agr system increases virulence factor expression during acute infections and, when inactive, enhances biofilm formation and persistence in chronic infections[5][7]. The system is a validated therapeutic target for anti-virulence approaches, and several drug candidates inhibit components within the agr pathway or antagonize AIP signaling[5][1]. The role of agr in different disease states requires careful consideration when developing therapeutics targeting this pathway[5].
Inhibition of AIP synthesis or signaling (blockade of AgrB, AgrC, or AgrA function); Disruption of AIP binding to its receptor AgrC; Antagonism of AgrA-mediated transcriptional activation; Inhibition of RNAIII synthesis, reducing virulence factor expression; Modulation of biofilm formation and dispersal
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Staphylococcus aureus accessory gene regulator quorum sensing system (agr quorum sensing system).